| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1044074107 |
| P356 | DOI | 10.1002/1529-0131(200109)44:9<2024::AID-ART351>3.0.CO;2-K |
| P698 | PubMed publication ID | 11592363 |
| P50 | author | Richard Reece | Q18757058 |
| Paul Emery | Q19859634 | ||
| Ursula Fearon | Q39025872 | ||
| Douglas J Veale | Q55686130 | ||
| P2093 | author name string | Fraser A | |
| Emery P | |||
| Alexander Fraser | |||
| Reece R | |||
| P2860 | cites work | MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes | Q24628843 |
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials | Q28369525 | ||
| Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression | Q35745301 | ||
| Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue | Q36363302 | ||
| Apoptosis in the rheumatic diseases | Q41640058 | ||
| Synovial cytokine and growth factor regulation of MMPs/TIMPs: implications for erosions and angiogenesis in early rheumatoid and psoriatic arthritis patients. | Q52865453 | ||
| Review: angiogenesis: implications for rheumatoid arthritis | Q74648923 | ||
| Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1 | Q77426354 | ||
| Complex role of matrix metalloproteinases in angiogenesis | Q77474882 | ||
| Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis | Q77766908 | ||
| Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis | Q77993356 | ||
| P433 | issue | 9 | |
| P921 | main subject | immunology | Q101929 |
| rheumatology | Q327657 | ||
| apoptotic process | Q14599311 | ||
| P304 | page(s) | 2024-2028 | |
| P577 | publication date | 2001-01-01 | |
| 2001-09-01 | |||
| P1433 | published in | Arthritis and Rheumatism | Q23929027 |
| P1476 | title | Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis | |
| P478 | volume | 44 |
| Q41201384 | Adiponectin may contribute to synovitis and joint destruction in rheumatoid arthritis by stimulating vascular endothelial growth factor, matrix metalloproteinase-1, and matrix metalloproteinase-13 expression in fibroblast-like synoviocytes more than |
| Q41208827 | Angiogenesis Dysregulation in Psoriatic Arthritis: Molecular Mechanisms |
| Q35553507 | Angiogenesis as a target in rheumatoid arthritis |
| Q36208106 | Angiogenesis in psoriasis and psoriatic arthritis: clues to disease pathogenesis |
| Q42156810 | Angiogenic and inflammatory properties of psoriatic arthritis |
| Q34718143 | Apoptosis as a therapeutic tool in rheumatoid arthritis |
| Q39308974 | Cellular and molecular perspectives in rheumatoid arthritis |
| Q22000875 | Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study |
| Q38582187 | Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha |
| Q22000831 | Decreased plasma levels of soluble CD18 link leukocyte infiltration with disease activity in spondyloarthritis |
| Q35638455 | Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment |
| Q84602508 | Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis |
| Q78312429 | Expression of PTHrP and its cognate receptor in the rheumatoid synovial microcirculation |
| Q26781647 | Immunopathology of synovitis: from histology to molecular pathways |
| Q36066372 | In vitro effects of platelet-rich gel supernatants on histology and chondrocyte apoptosis scores, hyaluronan release and gene expression of equine cartilage explants challenged with lipopolysaccharide. |
| Q36903488 | Pathophysiological mechanisms of angiogenesis. |
| Q37258222 | Pharmacological control of receptor of advanced glycation end-products and its biological effects in psoriasis |
| Q64251127 | Psoriatic Synovitis: Singularity and Potential Clinical Implications |
| Q36140890 | Recent findings on the role of gelatinases (matrix metalloproteinase-2 and -9) in osteoarthritis |
| Q44519335 | Suppression of collagen-induced arthritis by intra-articular lentiviral vector-mediated delivery of Toll-like receptor 7 short hairpin RNA gene. |
| Q35687019 | Synovial Tissue Response to Treatment with TNF Blockers in Peripheral Spondyloarthritis |
| Q73774988 | Synovial fluid exoglycosidases are predictors of rheumatoid arthritis and are effective in cartilage glycosaminoglycan depletion |
| Q24816628 | Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis |
| Q39708042 | Synovial tissue hypoxia and inflammation in vivo |
| Q37866683 | Synovitis in psoriatic arthritis: immunohistochemistry, comparisons with rheumatoid arthritis, and effects of therapy |
| Q59040804 | The pathogenesis of psoriatic arthritis |
| Q36139268 | Traditional and newer therapeutic options for psoriatic arthritis: an evidence-based review |
| Q55443497 | Transcription Factor SOX5 Promotes the Migration and Invasion of Fibroblast-Like Synoviocytes in Part by Regulating MMP-9 Expression in Collagen-Induced Arthritis. |
| Q34731141 | VEGF and imaging of vessels in rheumatoid arthritis |
| Q51658693 | Vascular perfusion kinetics by contrast-enhanced ultrasound are related to synovial microvascularity in the joints of psoriatic arthritis. |
| Q26778261 | What makes psoriatic and rheumatoid arthritis so different? |
| Q84599999 | [Psoriatic synovitis: pathogenic and therapeutic implications] |
Search more.